Thank you for submitting your report
multistep form
Search
Retinal Diseases
Retinal Diseases
Working at Boehringer Ingelheim
Working at Boehringer Ingelheim
Equine
Equine
Sustainable Development
Sustainable Development
Anna Race
Human Pharma's Sales Director for UK & Ireland, Anna Race discusses how she enjoys making a difference within the company.
Parasiticides
Science and Innovation - Animal Health Innovation - Parasiticides
Vaccines
Science and Innovation - Animal Health Innovation - Vaccines
Bovine
Bovine
Heart Diseases
Heart Diseases
Effective management practices for parasite control in cattle
Effective management practices for parasite control in cattle
The Hidden Cost of Parasites in Cattle
The Hidden Cost of Parasites in Cattle
How do you know if your cattle have parasites?
How do you know if your cattle have parasites?
Treatment options for parasite control in cattle
Treatment options for parasite control in cattle
Strategies for overcoming resistance in parasites
Strategies for overcoming resistance in parasites
ABIC-COPD
Discover the ABIC Fund, developed to advance health innovation projects in the area of respiratory diseases, like COPD, for Alberta-based investigators.
Machine learning for patients
Using AI to power patient-centric guideline optimization: discover the collaboration between Boehringer Ingelheim Canada, a community of cardiologists and Ensho Health.
ABILD
ABILD partnership aims at enhancing health innovation projects to comprehend care gaps in diagnosis, treatment, and access for Albertans with progressive fibrosing ILD.
Pommeraie collaborative COPD strategy
La Pommeraie's Collaborative COPD Strategy, with Boehringer Ingelheim Canada's Patient Access division, focuses on enhancing COPD patients' health and reducing hospitalizations.
Stefanie Bock Kreilinger
Stefanie Bock-Kreilinger works in the legal department at Boehringer Ingelheim as head of corporate legal medicine, evidence and digital health.
ABIC Indigenous Populations
Improving primary care in Alberta’s Indigenous Populations. Read more about ABIC, an example of how delivering innovative solutions can improve health equity.
Ryan Henri Rickards
Ryan Henry Rickards, a senior finance manager for US Animal Health Commercial Controlling team, highlights his career at Boehringer Ingelheim.
First Half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
Growing late-stage research pipeline, addressing areas of high unmet medical need Pipeline includes areas such as rare skin disease, pulmonary fibrosis, oncology and central nervous system disease Net sales rise currency-adjusted by 9.5 percent to 11.
Life forward - Boehringer Ingelheim unveils its evolved company brand
Ingelheim, Germany, 30/10/2023 | Boehringer Ingelheim, a leading research-driven biopharmaceutical company, on Monday presented a new corporate branding that is designed to inspire deeper connection with the company’s diverse customers, partners
First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas